Literature DB >> 11054588

Norepinephrine and the control of food intake.

P J Wellman1.   

Abstract

The focus of the present review is to reconsider the role of endogenous norepinephrine (NE) in brain, specifically within the hypothalamic paraventricular nucleus (PVN), with regard to its potential role in eliciting eating or satiety. The PVN is innervated by NE fibers and is a site at which infusion of exogenous NE elicits eating at low doses. Two subtypes of alpha-adrenergic receptors within the PVN exert antagonistic actions on eating in the rat: activation of PVN alpha(2)-adrenoceptors increases eating, whereas activation of PVN alpha(1)-adrenoceptors suppresses eating. Pharmacologic manipulations that elevate NE can increase or decrease food intake, depending on the site and type of NE manipulation. Certain antiobesity drugs may act to reduce eating via release of NE and subsequent activation of alpha(1)-adrenoceptors. The PVN exhibits a reliable rhythm in the secretion of endogenous NE over the dark-and-light cycle, and this rhythm may interact with changes in numbers of PVN alpha(1)- and alpha(2)-adrenoceptors to modulate eating during the dark-and-light cycle. Push-and-pull and microdialysis studies indicate that NE secretion is strongly associated with eating, particularly at the start of the dark phase. The present review considers potential interactions of NE with substances such as leptin and neuropeptide Y that alter eating.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054588     DOI: 10.1016/s0899-9007(00)00415-9

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  41 in total

Review 1.  Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions.

Authors:  Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-20       Impact factor: 3.619

2.  The Roles of Dopamine and α1-Adrenergic Receptors in Cocaine Preferences in Female and Male Rats.

Authors:  Adam N Perry; Christel Westenbroek; Lakshmikripa Jagannathan; Jill B Becker
Journal:  Neuropsychopharmacology       Date:  2015-04-22       Impact factor: 7.853

3.  The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.

Authors:  Udi E Ghitza; Sarah M Gray; David H Epstein; Kenner C Rice; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2005-12-07       Impact factor: 7.853

Review 4.  Obesity: Current and potential pharmacotherapeutics and targets.

Authors:  Vidya Narayanaswami; Linda P Dwoskin
Journal:  Pharmacol Ther       Date:  2016-10-20       Impact factor: 12.310

Review 5.  Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.

Authors:  Marcelo O Dietrich; Tamas L Horvath
Journal:  Nat Rev Drug Discov       Date:  2012-08-03       Impact factor: 84.694

6.  Involvement of histaminergic and noradrenergic receptors in the oxytocin-induced food intake in neonatal meat-type chicks.

Authors:  Seyed Vahid Mirnaghizadeh; Morteza Zendehdel; Vahab Babapour
Journal:  Vet Res Commun       Date:  2016-12-14       Impact factor: 2.459

7.  Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone rats.

Authors:  Peter J Vollbrecht; Kathryn M Nesbitt; Omar S Mabrouk; Aaron M Chadderdon; Emily M Jutkiewicz; Robert T Kennedy; Carrie R Ferrario
Journal:  Behav Brain Res       Date:  2017-11-09       Impact factor: 3.332

Review 8.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

9.  Intralateral hypothalamic area injection of isoproterenol and propranolol affects food and water intake in broilers.

Authors:  Ali Baghbanzadeh; Mohammad Reza Hajinezhad; Bahram Shohreh; Reza Maleklou
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2010-02-07       Impact factor: 1.836

Review 10.  Psychotropic drugs in the treatment of obesity: what promise?

Authors:  Jose C Appolinario; João R Bueno; Walmir Coutinho
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.